Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23547093.
- Also identified by DOI 10.3949/ccjm.80a.12182 and PMC identifier 3960994.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The emergence of carbapenem-resistant Enterobacteriaceae (CRE) highlights the importance of effective antibiotics to maintain the safety of our health care system. Clinicians will encounter CRE as a cause of difficult-to-treat and often fatal infections in hospitalized patients. We review the mechanisms of carbapenem resistance, the dissemination and clinical impact of these resistant organisms, and challenges to their detection, treatment, and control.
Medical subject headings
- Anti-Bacterial Agents
- Carbapenems
- Enterobacteriaceae
- Enterobacteriaceae Infections
- beta-Lactam Resistance